Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

171
Body:The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
171
Oxygen Transport in the Blood01:27

Oxygen Transport in the Blood

5.6K
Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
5.6K
Hemoglobin01:24

Hemoglobin

7.1K
Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
7.1K
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

5.3K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
5.3K
Gene Families01:57

Gene Families

9.7K
Gene families consist of groups of genes proposed to have originated from a common ancestor. Typically these arise through events in which a gene or genes are mistakenly duplicated during cell division. Unlike their parent genes (which are subject to selection pressure to maintain function), these gene copies do not need to preserve their sequences and may evolve at a relatively faster rate.
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
9.7K
Multiple Allele Traits01:49

Multiple Allele Traits

37.8K
The Concept of Multiple Allelism
37.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anal metastasis as the sentinel and isolated presentation of invasive ductal breast carcinoma.

Annals of the Royal College of Surgeons of England·2016
Same author

Cardiovascular effects of methacholine-induced airway obstruction in man.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2014
Same author

Humoral hypercalcaemia of malignancy associated with squamous cell carcinoma of the anus.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2011
Same author

Volatile organic compounds in runners near a roadway: increased blood levels after short-duration exercise.

British journal of sports medicine·2008
Same author

A novel imaging technique as an adjunct to the in vivo diagnosis of nonmelanoma skin cancer.

The British journal of dermatology·2006
Same author

Dilated cardiomyopathy masquerading as long QT syndrome.

Pediatric cardiology·2006
Same journal

Urinary protein vs albumin for assessing kidney failure risk in chronic kidney disease.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same journal

Systolic blood pressure and albuminuria reduction mediate cardiovascular benefits of finerenone in T2 diabetes and CKD.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same journal

Bortezomib-Cyclophosphamide-Dexamethasone versus Rituximab in PGNMID.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same journal

Prevalence of anti-rituximab antibodies in autoimmune forms of glomerulonephritis and podocytopathies.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same journal

Pathophysiology of pregnancy-associated acute kidney injury.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same journal

Risk of CKD in biopsy-proven metabolic dysfunction-associated steatotic liver disease.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
See all related articles

Related Experiment Videos

Haemoglobin--is more better?

J Walls1

  • 1Department of Nephrology, Leicester General Hospital, UK.

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Recombinant human erythropoietin (r-HuEPO) therapy in dialysis patients may improve quality of life. However, careful monitoring of haemoglobin and blood pressure is crucial due to potential haemodynamic changes and adverse effects.

Related Experiment Videos

Area of Science:

  • Nephrology
  • Cardiology
  • Hematology

Background:

  • Recombinant human erythropoietin (r-HuEPO) is used to treat anemia in dialysis patients.
  • r-HuEPO treatment is associated with improved quality of life, linked to hemoglobin levels up to 35% hematocrit.
  • Potential benefits of higher hemoglobin targets need to be weighed against hemodynamic changes.

Purpose of the Study:

  • To evaluate the effects of r-HuEPO on cardiac output and left ventricular mass.
  • To assess the relationship between hemoglobin levels and quality of life in dialysis patients.
  • To determine optimal hematocrit targets for r-HuEPO therapy.

Main Methods:

  • The study likely involved analyzing hemodynamic parameters and cardiac structure in dialysis patients undergoing r-HuEPO treatment.
  • Quality of life assessments were correlated with hemoglobin and hematocrit levels.
  • Adverse effects on the coagulation system and microcirculation were considered.

Main Results:

  • r-HuEPO treatment was found to reduce cardiac output and increase left ventricular mass.
  • Quality of life improvements were observed up to a hematocrit of 35%.
  • Increased peripheral resistance, hypertension, and potential adverse effects on coagulation and microcirculation were noted.

Conclusions:

  • A target hematocrit of 34-37% appears reasonable for r-HuEPO therapy in dialysis patients.
  • Individualized hematocrit targets based on symptoms and lifestyle may be appropriate.
  • Further trials are needed to investigate higher hemoglobin targets (14 g/dl or 40% hematocrit).